Esperion Therapeutics (ESPR) Times Interest Earned (2019 - 2025)
Historic Times Interest Earned for Esperion Therapeutics (ESPR) over the last 7 years, with Q3 2025 value amounting to -$0.45.
- Esperion Therapeutics' Times Interest Earned rose 5749.68% to -$0.45 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.37, marking a year-over-year decrease of 23184.59%. This contributed to the annual value of $0.92 for FY2024, which is 13480.87% up from last year.
- Latest data reveals that Esperion Therapeutics reported Times Interest Earned of -$0.45 as of Q3 2025, which was up 5749.68% from $0.35 recorded in Q2 2025.
- In the past 5 years, Esperion Therapeutics' Times Interest Earned registered a high of $5.15 during Q1 2024, and its lowest value of -$10.19 during Q1 2021.
- Its 5-year average for Times Interest Earned is -$2.2, with a median of -$2.81 in 2023.
- As far as peak fluctuations go, Esperion Therapeutics' Times Interest Earned soared by 25253.5% in 2024, and later crashed by 12206.67% in 2025.
- Quarter analysis of 5 years shows Esperion Therapeutics' Times Interest Earned stood at -$4.14 in 2021, then increased by 28.37% to -$2.97 in 2022, then grew by 5.16% to -$2.81 in 2023, then soared by 90.43% to -$0.27 in 2024, then plummeted by 67.8% to -$0.45 in 2025.
- Its Times Interest Earned was -$0.45 in Q3 2025, compared to $0.35 in Q2 2025 and -$1.14 in Q1 2025.